305 related articles for article (PubMed ID: 28874440)
1. Blocking gp130 signaling suppresses autotaxin expression in adipocytes and improves insulin sensitivity in diet-induced obesity.
Sun S; Wang R; Song J; Guan M; Li N; Zhang X; Zhao Z; Zhang J
J Lipid Res; 2017 Nov; 58(11):2102-2113. PubMed ID: 28874440
[TBL] [Abstract][Full Text] [Related]
2. Involvement of autotaxin/lysophosphatidic acid signaling in obesity and impaired glucose homeostasis.
Rancoule C; Dusaulcy R; Tréguer K; Grès S; Attané C; Saulnier-Blache JS
Biochimie; 2014 Jan; 96():140-3. PubMed ID: 23639740
[TBL] [Abstract][Full Text] [Related]
3. Autotaxin-LPA signaling contributes to obesity-induced insulin resistance in muscle and impairs mitochondrial metabolism.
D'Souza K; Nzirorera C; Cowie AM; Varghese GP; Trivedi P; Eichmann TO; Biswas D; Touaibia M; Morris AJ; Aidinis V; Kane DA; Pulinilkunnil T; Kienesberger PC
J Lipid Res; 2018 Oct; 59(10):1805-1817. PubMed ID: 30072447
[TBL] [Abstract][Full Text] [Related]
4. Autotaxin Is Regulated by Glucose and Insulin in Adipocytes.
D'Souza K; Kane DA; Touaibia M; Kershaw EE; Pulinilkunnil T; Kienesberger PC
Endocrinology; 2017 Apr; 158(4):791-803. PubMed ID: 28324037
[TBL] [Abstract][Full Text] [Related]
5. Lysophosphatidic Acid Signaling in Obesity and Insulin Resistance.
D'Souza K; Paramel GV; Kienesberger PC
Nutrients; 2018 Mar; 10(4):. PubMed ID: 29570618
[TBL] [Abstract][Full Text] [Related]
6. Mesenteric Fat Lipolysis Mediates Obesity-Associated Hepatic Steatosis and Insulin Resistance.
Wueest S; Item F; Lucchini FC; Challa TD; Müller W; Blüher M; Konrad D
Diabetes; 2016 Jan; 65(1):140-8. PubMed ID: 26384383
[TBL] [Abstract][Full Text] [Related]
7. Adipose-specific disruption of autotaxin enhances nutritional fattening and reduces plasma lysophosphatidic acid.
Dusaulcy R; Rancoule C; Grès S; Wanecq E; Colom A; Guigné C; van Meeteren LA; Moolenaar WH; Valet P; Saulnier-Blache JS
J Lipid Res; 2011 Jun; 52(6):1247-1255. PubMed ID: 21421848
[TBL] [Abstract][Full Text] [Related]
8. Superantigen activates the gp130 receptor on adipocytes resulting in altered adipocyte metabolism.
Banke E; Rödström K; Ekelund M; Dalla-Riva J; Lagerstedt JO; Nilsson S; Degerman E; Lindkvist-Petersson K; Nilson B
Metabolism; 2014 Jun; 63(6):831-40. PubMed ID: 24684823
[TBL] [Abstract][Full Text] [Related]
9. Gp130 cytokines exert differential patterns of crosstalk in adipocytes both in vitro and in vivo.
White UA; Stewart WC; Stephens JM
Obesity (Silver Spring); 2011 May; 19(5):903-10. PubMed ID: 21164505
[TBL] [Abstract][Full Text] [Related]
10. Targeting the ERK signaling pathway as a potential treatment for insulin resistance and type 2 diabetes.
Ozaki KI; Awazu M; Tamiya M; Iwasaki Y; Harada A; Kugisaki S; Tanimura S; Kohno M
Am J Physiol Endocrinol Metab; 2016 Apr; 310(8):E643-E651. PubMed ID: 26860984
[TBL] [Abstract][Full Text] [Related]
11. Oncostatin M suppresses browning of white adipocytes via gp130-STAT3 signaling.
van Krieken PP; Odermatt TS; Borsigova M; Blüher M; Wueest S; Konrad D
Mol Metab; 2021 Dec; 54():101341. PubMed ID: 34547509
[TBL] [Abstract][Full Text] [Related]
12. Autotaxin is released from adipocytes, catalyzes lysophosphatidic acid synthesis, and activates preadipocyte proliferation. Up-regulated expression with adipocyte differentiation and obesity.
Ferry G; Tellier E; Try A; Grés S; Naime I; Simon MF; Rodriguez M; Boucher J; Tack I; Gesta S; Chomarat P; Dieu M; Raes M; Galizzi JP; Valet P; Boutin JA; Saulnier-Blache JS
J Biol Chem; 2003 May; 278(20):18162-9. PubMed ID: 12642576
[TBL] [Abstract][Full Text] [Related]
13. Dexamethasone decreases the autotaxin-lysophosphatidate-inflammatory axis in adipose tissue: implications for the metabolic syndrome and breast cancer.
Meng G; Tang X; Yang Z; Zhao Y; Curtis JM; McMullen TPW; Brindley DN
FASEB J; 2019 Feb; 33(2):1899-1910. PubMed ID: 30192654
[TBL] [Abstract][Full Text] [Related]
14. IL-6-Type Cytokine Signaling in Adipocytes Induces Intestinal GLP-1 Secretion.
Wueest S; Laesser CI; Böni-Schnetzler M; Item F; Lucchini FC; Borsigova M; Müller W; Donath MY; Konrad D
Diabetes; 2018 Jan; 67(1):36-45. PubMed ID: 29066599
[TBL] [Abstract][Full Text] [Related]
15. Effects of leukemia inhibitory factor on 3T3-L1 adipocytes.
Hogan JC; Stephens JM
J Endocrinol; 2005 Jun; 185(3):485-96. PubMed ID: 15930175
[TBL] [Abstract][Full Text] [Related]
16. Production of extracellular lysophosphatidic acid in the regulation of adipocyte functions and liver fibrosis.
Yang F; Chen GX
World J Gastroenterol; 2018 Sep; 24(36):4132-4151. PubMed ID: 30271079
[TBL] [Abstract][Full Text] [Related]
17. ADSCs and adipocytes are the main producers in the autotaxin-lysophosphatidic acid axis of breast cancer and healthy mammary tissue in vitro.
Schmid R; Wolf K; Robering JW; Strauß S; Strissel PL; Strick R; Rübner M; Fasching PA; Horch RE; Kremer AE; Boos AM; Weigand A
BMC Cancer; 2018 Dec; 18(1):1273. PubMed ID: 30567518
[TBL] [Abstract][Full Text] [Related]
18. Adipocytes affect castration-resistant prostate cancer cells to develop the resistance to cytotoxic action of NK cells with alterations of PD-L1/NKG2D ligand levels in tumor cells.
Xu L; Shen M; Chen X; Zhu R; Yang DR; Tsai Y; Keng PC; Chen Y; Lee SO
Prostate; 2018 Apr; 78(5):353-364. PubMed ID: 29330929
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of insulin sensitivity by free fatty acids requires activation of multiple serine kinases in 3T3-L1 adipocytes.
Gao Z; Zhang X; Zuberi A; Hwang D; Quon MJ; Lefevre M; Ye J
Mol Endocrinol; 2004 Aug; 18(8):2024-34. PubMed ID: 15143153
[TBL] [Abstract][Full Text] [Related]
20. Effects of cardiotrophin on adipocytes.
Zvonic S; Hogan JC; Arbour-Reily P; Mynatt RL; Stephens JM
J Biol Chem; 2004 Nov; 279(46):47572-9. PubMed ID: 15339920
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
